Coumarins

<p>M04120 - 4-Methylumbelliferyl N-acetyl-beta-D-galactosaminide</p>

<p>Applications Coumarin is a pharmaceutic aid (flavor) that is found in tonka beans, levender oil, woodruff, sweet clover.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Hazleton, L., et al.: J. Pharmacol. Exp. Ther., 118, 348 (1956); Lake, B., et al.: Food Chem. Toxicol., 37, 423 (1999); Frerot, E., et al.: Flavour Fragrance J., 17, 218 (2002); Yang, Z., et al.: Food Chem., 114, 289 (2009);<br></p>

<p>Applications Imperatorin (cas# 482-44-0) is a compound useful in organic synthesis.<br></p>

<p>Applications Metabolite of 7-hydroxycoumarin (7-HC). Found in hepatocyte, microsome, S9 fraction of human, dog, monkey, rat and mouse liver.<br>References Ekins, S., et al.: Drug Metab. Dispos. 24, 990 (1996), Bock, K., et al.: Biochem. Pharmacol. 66, 691 (2003), Naritomi, Y., et al.: Drug Metab. Dispos. 31, 580 (2003).<br></p>

<p>Applications 7-Hydroxy Coumarin-d5 is the labeled analogue of 7-Hydroxy Coumarin (H924875), a metabolite of Coumarin that is present in many plants and is the aglucon of skimmin.<br>References Schilling, et al.: Nature, 221, 664 (1969); Indahl, S., et al.: Xenobiotica, 1, 13 (1971); Thompson, S.G., et al.: Antimicrob. Agents Chemother., 18, 264 (1980)<br></p>

<p>4-Methylesculetin is a coumarin derivative, which is a type of organic compound. This compound is primarily sourced from various plant species, where it occurs naturally as a secondary metabolite. Known for its bioactive properties, 4-Methylesculetin exhibits significant antioxidant activity by scavenging free radicals and protecting against oxidative stress.</p>

<p>Fraxin is a naturally occurring anticoagulant, which is derived from the bark of certain species of the Fraxinus tree. It functions by inhibiting thrombin and other key enzymes in the coagulation cascade, thus preventing the formation of blood clots. This mode of action makes it particularly valuable in research settings focused on cardiovascular diseases, as well as in the development of therapeutic agents targeting coagulopathies.</p>